Snowball logo
logo
6039

Hunan Fangsheng Pharm Co Ltd

603998 SHG
¥10.64-¥0.20  (1.85%)
Estimate
P/E
14
EPS
0.76
Beta
0.278
Growth
Revenue, YoY
10.69%
Net income, YoY
0.15%
FCF, YoY
1,212.04%
Forecast
P/E (FWD)
10.7
EPS (FWD)
0.99
About the company
Ticker
603998
ISIN
CNE100001VG6
Country
China
Sector (GICS)
Healthcare
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological drugs, and anti-infective drugs. Its products include Xuesaitong dispersible tablets; Xuesaitong tablets; Garcinia Cambogia bone strengthening tablets; Lysine Vitamin B12 granules; Cephalosporin tablets, Jinying capsules; Pudilan anti-inflammatory tablets; Tenghuang Jian Gu tablets; Xiaoer Jingxing Zhike granules; Yizhemaibu tablets; Xuanqi Jian tablets; Xuanqi Jian Gu tablets, Qiangli Pipa Gao, strong loquat syrup, and others. Hunan Fangsheng Pharmaceutical Co., Ltd. was founded in 2000 and is based in Changsha, China.

Frequently asked questions

What sector does Hunan Fangsheng Pharm Co Ltd (603998) operate in?

Hunan Fangsheng Pharm Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Hunan Fangsheng Pharm Co Ltd (603998) current stock price?

As of the latest data, Hunan Fangsheng Pharm Co Ltd stock price is CN¥10.64, with a previous close of CN¥10.84. Hunan Fangsheng Pharm Co Ltd lost -CN¥0.20 in the last trading session, representing a -1.85% loss.

What is Hunan Fangsheng Pharm Co Ltd (603998) current market capitalization?

Hunan Fangsheng Pharm Co Ltd market cap is approximately 4.67 billion.

What is Hunan Fangsheng Pharm Co Ltd (603998) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.76, and the forward EPS is CN¥0.99.

What is Hunan Fangsheng Pharm Co Ltd (603998) Price-to-Earnings (P/E) ratio?

Hunan Fangsheng Pharm Co Ltd current P/E ratio is 14, with a forward P/E of 10.75.

Does Hunan Fangsheng Pharm Co Ltd (603998) pay dividends?

No. Hunan Fangsheng Pharm Co Ltd does not pay a dividend.

What is Hunan Fangsheng Pharm Co Ltd (603998) beta (volatility) score?

Hunan Fangsheng Pharm Co Ltd has a beta of 0.278, indicating lower volatility than the overall market.